John Baldoni

Insider Reports History

Location
Lexington, MA
Signature
By: /s/ Christine Klaskin, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Baldoni:

Company Role Class Num Shares Value Price $ Report Date Ownership
MiNK Therapeutics, Inc. Director Common stock 41,193 $42,841 $1.04 01 Sep 2023 Direct
MiNK Therapeutics, Inc. Director Stock Option (Right to Buy) 22,500 14 Jun 2023 Direct

Insider Reports Filed by John Baldoni

Symbol Company Period Transactions Value $ Form Type Role Filing Time
INKT MiNK Therapeutics, Inc. 01 Sep 2023 1 +$14,375 4 Director 06 Sep 2023, 18:01
INKT MiNK Therapeutics, Inc. 14 Jun 2023 1 $0 4 Director 16 Jun 2023, 20:07
INKT MiNK Therapeutics, Inc. 01 Jun 2023 1 +$14,376 4 Director 02 Jun 2023, 19:39
INKT MiNK Therapeutics, Inc. 01 Mar 2023 1 +$14,375 4 Director 03 Mar 2023, 14:00
INKT MiNK Therapeutics, Inc. 01 Dec 2022 1 +$14,376 4 Director 05 Dec 2022, 16:22
INKT MiNK Therapeutics, Inc. 15 Sep 2022 1 +$28,752 4 Director 19 Sep 2022, 19:10
INKT MiNK Therapeutics, Inc. 09 Mar 2022 1 $0 4 Director 11 Mar 2022, 15:12
INKT MiNK Therapeutics, Inc. 13 Oct 2021 0 $0 3 Director 20 Oct 2021, 18:57